
Origin
AI and Data for Cancer Therapeutics
About
We produce patient-derived cancer datasets for licensing to pharmaceutical and AI companies. Our data comprises matched spatial transcriptomics, H&E and clinical labels. We operate our own laboratory, where samples are processed. Samples are sourced from leading biobank / hospital networks.
As R&D workflows increasingly rely on frontier AI systems, we believe there is critical need for real world datapoints so that findings translate in the clinic.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 8 employees
- YC batch
- Winter 2026
- Status
- Active
- Stage
- Early stage





